Startup Masterclasess: Meet the contestants in the Pitch Battle!
One of the most exciting parts of Life Sciences Baltics have already started! On 24-25 September 26 startups from Lithuania, Latvia, Estonia, Belarus and Ukraine learned many things in the Life Sciences Baltics Startup Masterclasses presented by Johnson & Johnson Innovation. During the Pitch Battle 10 promising and inspiring life sciences startups will be given a stage to showcase their ideas.
10 finalists will present startup in the Johnson & Johnson Innovation Hall on the second day of the Life Sciences Baltics event with a pitch to an audience of international investors, media and of course, the jury. They all compete for the exciting prizes – mentorship at Johnson & Johnson innovation, visit to the US Akron Biomedical Corridor and legal advice provided by Rödl & Partner.
This year life sciences startups showed significantly higher interest in applying to participate in the Startup Masterclasses by Johnson & Johnson Innovation. Not surprisingly, as in the Baltics life sciences startups have been contributing more and more to the overall industry dynamism in recent years.
Without further ado, here are all the announced startups to compete at the Pitch Challenge:
- Oculus Diagnostics
- Verita Cell
- Alternative Plants
- Pure Ruhe
Lithuanian startup Oxipit was crowned the winner of Pitch Challenge by Johnson & Johnson Innovation winner at Life Sciences Baltics on 27 September. A startup that uses AI to diagnose cancer beat out 9 other startups in the Pitch Challenge which consisted of four minute pitches and Q&A session.
Over recent several years 7–8 life sciences spin-offs and startups have been establishing in Lithuania annually. They are developing pharmaceutical and biotechnological products of high added value as well as medical devices. The survey of life sciences companies conducted by Enterprise Lithuania in summer revealed that the development of promising companies of this sector largely depends on sufficient financing in every stage of business development.